Search for: "Sosei Group"
Sosei to Acquire Activus Pharma
HSMN NewsFeed,
21 Jun 2010:
Biopharmaceuticals, Mergers & Acquisitions
[Sosei Group, Activus Pharma]
|
Sosei Signs Definitive Distribution Agreement With ASKA for Commercialisation of SOH-075 (NorLevo(R))
HSMN NewsFeed,
2 Nov 2009:
Biopharmaceuticals, Distribution
[Sosei Group, ASKA Pharmaceuticals, SOH-075, NorLevo, morning after pill]
|
Sosei Agrees Terms With ASKA for Commercialisation of SOH-075 (NorLevo(R))
HSMN NewsFeed,
22 Oct 2008:
Biopharmaceuticals
[Sosei, ASKA Pharmaceuticals, emergency contraceptive pill, SOH-075, NorLevo]
|
Sosei Announces Completion of Phase III Trial for NorLevo(R)
HSMN NewsFeed,
10 Jul 2008:
Biopharmaceuticals
[Sosei, NorLevo, SOH-075, emergency contraceptive]
|
Sosei Announces Outcome of Strategy Review
HSMN NewsFeed,
14 May 2008:
Biopharmaceuticals
[Sosei Group, AD923, NVA237/QVA149]
|
Sosei Announces Start of AD 923 Phase III Studies in Europe
HSMN NewsFeed,
12 Feb 2008:
Biopharmaceuticals, Drug Delivery
[Sosei Group, fentanyl sublingual spray, AD 923]
|
Amarin Announces Management Changes Including Appointment of New CEO
HSMN NewsFeed,
19 Dec 2007:
Biopharmaceuticals, Personnel
[Amarin Corp]
|
Sosei Announces Approval to Start AD 923 Phase III Studies in Europe
HSMN NewsFeed,
28 Nov 2007:
Biopharmaceuticals, Drug Delivery, Regulatory
[Sosei Group, fentanyl sublingual spray, AD 923]
|
Sosei Announces Completion of Phase II Trial of AD 337 in Fibromyalgia Syndrome
HSMN NewsFeed,
18 Sep 2007:
Biopharmaceuticals
[Sosei, AD 337, fibromyalgia]
|
|
|
Public
Feeds 
Full text >>